Patents by Inventor Anthony Keller
Anthony Keller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240148249Abstract: Methods and systems for body monitoring are disclosed. The methods and systems include: obtaining one or more sensor data arrays from one or more sensors. A first sensor data array of the one or more sensor data arrays includes multiple samples, the first sensor data array corresponding to a first sensor of the one or more sensors. generating a lifted dataset for the plurality of samples in the first sensor data array based on a lifting scheme; determine a sensor-specific threshold based on the first sensor; filtering the lifted dataset based on the sensor-specific threshold to produce a filtered dataset; generating a plurality of run-length encoding arrays based on the filtered dataset; concatenating the plurality of run-length encoding arrays to produce a packet; encrypt the packet; and transmit the encrypted packet. Other aspects, embodiments, and features are also claimed and described.Type: ApplicationFiled: November 3, 2022Publication date: May 9, 2024Inventors: Robert Anthony Karam, Myles Joseph Keller
-
Patent number: 11969502Abstract: A composition configured for oral use is provided, the composition including a filler in an amount of at least 20% by weight, based on the total weight of the composition, and at least one active ingredient including one or more botanical materials, stimulants, amino acids, vitamins, antioxidants, cannabinoids, pharmaceutical agents, or a combination thereof. The composition further includes a salt and at least one sweetener. The composition has a moisture content of at least about 40% by weight, based on the total weight of the composition.Type: GrantFiled: February 24, 2021Date of Patent: April 30, 2024Assignee: NICOVENTURES TRADING LIMITEDInventors: Christopher Keller, Ronald K. Hutchens, Thomas H. Poole, Nicolas Von Cosmos, Anthony Richard Gerardi, Chris J. Grimes, Steven Lee Alderman, Darrell Eugene Holton, Jr., Ross Jay Oden, Matthew Evan Lampe, Michael Andrew Zawadzki, Kristen Spielbauer
-
Publication number: 20240013128Abstract: A computer-implemented method can be used for determining a sustainability score. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and determining a sustainability score based on the identified marker of the sample of the plastic compound.Type: ApplicationFiled: November 19, 2021Publication date: January 11, 2024Applicant: BASF SEInventors: Marina Grace Dickens Leed, Gazi Tuerkoglu, Wilhelm Keller, Martina Solfrank, Robert Anthony Keller, Oilver Reich, David Leino Calleja, Li Noi Lilian Hoh, Oliver Kuhn, Shyam Sundar Sathyanarayana, Kai Pahnke, Tobias Eltze, Christian Beil
-
Publication number: 20240009710Abstract: A computer-implemented method can be used for controlling sorting of plastic compounds. The method involves providing a computer-based database containing entries on a plurality of markers each identifying a specific plastic compound; receiving scan data from a sample of a plastic compound; identifying a marker in the sample of the plastic compound based on the received scan data and the plurality of markers of the database; and sorting of plastic compounds based on the identified marker of the sample of the plastic compound.Type: ApplicationFiled: November 19, 2021Publication date: January 11, 2024Applicant: BASF SEInventors: Gazi TUERKOGLU, Marina Grace Dickens Leed, Wilhelm Keller, Martina Solfrank, Robert Anthony Keller, Oliver Reich, David Leino Calleja, Li Noi Lilian Hoh, Oliver Kuhn, Shyam Sundar Sathyanarayana, Kai Pahnke, Tobias Eltze, Christian Beil
-
Publication number: 20230240984Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: October 28, 2022Publication date: August 3, 2023Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Publication number: 20200297625Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: January 27, 2020Publication date: September 24, 2020Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 10596109Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: GrantFiled: December 1, 2017Date of Patent: March 24, 2020Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20180214373Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: ApplicationFiled: December 1, 2017Publication date: August 2, 2018Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20180092838Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: November 22, 2017Publication date: April 5, 2018Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 9855212Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: GrantFiled: October 29, 2010Date of Patent: January 2, 2018Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Patent number: 9839609Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: GrantFiled: October 29, 2010Date of Patent: December 12, 2017Assignee: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 8524657Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: GrantFiled: August 2, 2011Date of Patent: September 3, 2013Assignee: University of WollongongInventors: Timothy Patrick Boyle, John Barnard Bremmer, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Publication number: 20130045941Abstract: Embodiments of the invention relate generally to formulations comprising dimethylsulfoxide (DMSO) alone or in combination with methylsulfonylmethane (MSM), and one or more therapeutic agents, and uses of such formulations to treat infectious diseases. In several embodiments, such formulations are effective in treating drug-resistant infectious diseases, for example, drug-resistant tuberculosis.Type: ApplicationFiled: October 29, 2010Publication date: February 21, 2013Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Rodney Benjamin, Anthony Keller, Jeff Varelman
-
Publication number: 20120207827Abstract: Embodiments of the invention relate generally to the use of formulations comprising DMSO and MSM to treat arthritis (such as osteoarthritis), pain, inflammation, and/or degeneration. DMSO and MSM formulations are administered orally and/or topically in several embodiments and provide effective treatment of both chronic and acute symptoms of arthritis (e.g., osteoarthritis), pain, inflammation, and/or degeneration. Solid forms of DMSO are provided in several embodiments.Type: ApplicationFiled: October 29, 2010Publication date: August 16, 2012Applicant: Abela Pharmaceuticals, Inc.Inventors: Colette Cozean, Jesse Cozean, Rodney Benjamin, Anthony Keller
-
Patent number: 8217085Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.Type: GrantFiled: February 17, 2012Date of Patent: July 10, 2012Assignee: Biogenic Innovations, LLCInventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
-
Publication number: 20120149672Abstract: Embodiments of the invention relate generally to the use of compositions comprising methylsulfonylmethane (MSM), and one or more therapeutic agents, for the treatment of drug-sensitive and drug resistant microorganisms. In several embodiments, such compositions are effective in treating drug resistant infectious diseases, for example, MRSA.Type: ApplicationFiled: February 17, 2012Publication date: June 14, 2012Inventors: Rodney Benjamin, Jeffrey Varelman, Anthony Keller
-
Publication number: 20110312875Abstract: The present invention provides a compound of formula I, II, III and IV as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: ApplicationFiled: August 2, 2011Publication date: December 22, 2011Applicant: UNIVERSITY OF WOLLONGONGInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Patent number: 8039430Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: GrantFiled: September 21, 2005Date of Patent: October 18, 2011Assignee: University of WollongongInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Joseph Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson
-
Publication number: 20080300287Abstract: The present invention provides a compound of formula (I), (II), (III) and (IV) as defined herein and pharmaceutically acceptable derivatives thereof. The present invention further provides use of the compounds of the present invention in the treatment of bacterial infection and in the treatment of HIV infection. Also provided are pharmaceutical compositions comprising the compounds of the present invention.Type: ApplicationFiled: September 21, 2005Publication date: December 4, 2008Applicant: UNIVERSITY OF WOLLONGONGInventors: Timothy Patrick Boyle, John Barnard Bremner, Zinka Brkic, Jonathan Alan Victor Coates, Neal Kevin Dalton, John Deadman, Paul Anthony Keller, Jody Morgan, Stephen Geoffrey Pyne, David Ian Rhodes, Mark James Robertson